GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Breakout Stocks of Week 34

NASDAQ was down last week (week 33) by -0.0867% ending at 14,822.90 points after falling -12.86 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Ikonics Corporation NASDAQ:IKNX. This stock has had a buy signal since Jun 04, 2021 when the price was $10.87 and is so far up 125.39% to $24.50. Some other companies are on our watchlist to, among these are Vanguard S&P 500 Growth Index Fund ETF Shares NYSEARCA:VOOG iShares Core S&P U.S. Growth ETF NYSEARCA:IUSG MSCI Inc NYSE:MSCI and Bruker Corporation NASDAQ:BRKR which all got a breakout pattern emerging.

Date Company Price Week 34
Aug 13, 2021 Ikonics Corporation $24.50 $23.51 -4.04%
Aug 13, 2021 Vanguard S&p 500 Growth Index Fund Etf Shares $276.14 $276.58 0.159%
Aug 13, 2021 Ishares Core S&p U.s. Growth Etf $106.00 $106.16 0.151%
Aug 13, 2021 Msci Inc $630.02 $618.86 -1.77%
Aug 13, 2021 Bruker Corporation $82.92 $84.16 1.50%

Ikonics Corporation

NASDAQ:IKNX Strong Buy Candidate Score: 8.28
Strong Buy Candidate Score: 8.28 Aug 13, 2021

Ikonics CorporationThe Ikonics Corporation stock price gained 2.17% on the last trading day (Friday, 13th Aug 2021), rising from $23.98 to $24.50. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.87% from a day low at $24.00 to a day high of $25.65. The price has been going up and down for this period, and there has been a 12.54% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 80 thousand more shares were traded than the day before. In total, 107 thousand shares were bought and sold for approximately $2.62 million.

Ikonics Corporation holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About Ikonics Corporation:
IKONICS Corporation develops, manufactures, and sells photosensitive liquids and films for the screen printing, and awards and recognition industries primarily in the United States. It operates through five segments: Domestic, Export, IKONICS Imaging, Digital Texturing, and AMS. The company sells screen printing films, emulsions, and inkjet receptive films to distributors; and photo resistant films, art supplies, glass, metal medium, and related abrasive etching equipment to end user customers. It also provides sound deadening technology to the aerospace industry; products and services for etched composites, ceramics, glass, and silicon wafers; and products related to proprietary inkjet technology used for mold texturing and prototyping. The company markets and sells its products directly, as well as through domestic and international distributors, magazine advertising, trade shows, and the Internet. IKONICS Corporation also exports its products primarily to North America, Europe, Latin America, Asia, and internationally. The company was formerly known as The Chromaline Corporation and changed its name to IKONICS Corporation in December 2002. IKONICS Corporation was founded in 1952 and is based in Duluth, Minnesota.

Vanguard S&P 500 Growth Index Fund ETF Shares

NYSEARCA:VOOG Strong Buy Candidate Score: 6.29
Strong Buy Candidate Score: 6.29 Aug 13, 2021

The Vanguard S&P 500 Growth Index Fund ETF price gained 0.356% on the last trading day (Friday, 13th Aug 2021), rising from $275.16 to $276.14. During the last trading day the ETF fluctuated 0.394% from a day low at $275.06 to a day high of $276.14. The price has been going up and down for this period, and there has been a 1.42% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 162 thousand more shares were traded than the day before. In total, 243 thousand shares were bought and sold for approximately $67.09 million.

Vanguard S&P 500 Growth Index Fund holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About Vanguard S&P 500 Growth Index Fund ETF Shares:
The advisor employs an indexing investment approach designed to track the performance of the S&P 500® Growth Index, which represents the growth companies, as determined by the index sponsor, of the S&P 500 Index. The index measures the performance of large-capitalization growth companies in the United States.

iShares Core S&P U.S. Growth ETF

NYSEARCA:IUSG Strong Buy Candidate Score: 6.27
Strong Buy Candidate Score: 6.27 Aug 13, 2021

The iShares Core S&P U.S. Growth ETF price gained 0.341% on the last trading day (Friday, 13th Aug 2021), rising from $105.64 to $106.00. During the last trading day the ETF fluctuated 0.390% from a day low at $105.65 to a day high of $106.06. The price has been going up and down for this period, and there has been a 1.33% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 520 thousand more shares were traded than the day before. In total, 717 thousand shares were bought and sold for approximately $76.00 million.

iShares Core S&P U.S. Growth holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About iShares Core S&P U.S. Growth ETF:
The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.

MSCI Inc

NYSE:MSCI Strong Buy Candidate Score: 5.61
Strong Buy Candidate Score: 5.61 Aug 13, 2021

MSCI IncThe MSCI Inc stock price gained 0.777% on the last trading day (Friday, 13th Aug 2021), rising from $625.16 to $630.02. During the last trading day the stock fluctuated 1.80% from a day low at $619.81 to a day high of $630.98. The price has risen in 7 of the last 10 days and is up by 5.72% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 16 thousand more shares were traded than the day before. In total, 257 thousand shares were bought and sold for approximately $162.22 million.

On Jan 05, 2024, it was reported that Raymond James gave MSCI a "Market Perform" grade with a "downgrade" action.

MSCI Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About MSCI Inc:
MSCI Inc., together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. It operates through four segments: Index, Analytics, ESG and Climate, and All Other – Private Assets. The Index segment provides indexes for use in various areas of the investment process, including indexed product creation, such as ETFs, mutual funds, annuities, futures, options, structured products, over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct. The Analytics segment offers risk management, performance attribution and portfolio management content, application, and service that provides an integrated view of risk and return, and an analysis of market, credit, liquidity, and counterparty risk across asset classes; managed services, including consolidation of client portfolio data from various sources, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments. The ESG and Climate segment provides products and services that help institutional investors understand how ESG factors impact the long-term risk and return of their portfolio and individual security-level investments; and data, ratings, research, and tools to help investors navigate increasing regulation. The All Other – Private Assets segment includes real estate market and transaction data, benchmarks, return-analytics, climate assessments and market insights for funds, investors, and managers; business intelligence to real estate owners, managers, developers, and brokers; and offers investment decision support tools for private capital. It serves asset owners and managers, financial intermediaries, wealth managers, real estate professionals, and corporates. MSCI Inc. was incorporated in 1998 and is headquartered in New York, New York.

Bruker Corporation

NASDAQ:BRKR Strong Buy Candidate Score: 5.58
Strong Buy Candidate Score: 5.58 Aug 13, 2021

Bruker CorporationThe Bruker Corporation stock price gained 0.290% on the last trading day (Friday, 13th Aug 2021), rising from $82.68 to $82.92. During the last trading day the stock fluctuated 0.789% from a day low at $82.35 to a day high of $83.00. The price has risen in 6 of the last 10 days and is up by 0.81% over the past 2 weeks. Volume fell on the last day by -150 thousand shares and in total, 371 thousand shares were bought and sold for approximately $30.77 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

On Feb 15, 2024, it was reported that UBS gave BRKR a "Buy" grade with a "hold" action.

Bruker Corporation holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

About Bruker Corporation:
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

.

StockInvest.usStock Podcast